Abstract
Cardiac fibrosis is a pathological feature of myocardium of failing heart and plays causative roles in arrhythmia and cardiac dysfunction, but its regulatory mechanisms remain largely elusive. In this study, we investigated the effects of a novel EP4 receptor agonist ONO-0260164 on cardiac fibrosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have